Cargando…

Bortezomib/dexamethasone: COVID-19 infection: case report

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7791940/ http://dx.doi.org/10.1007/s40278-021-88715-3

Ejemplares similares

Bortezomib/dexamethasone: Covid-19 pneumonia: case report
Publicado: (2021)

Bortezomib/cyclophosphamide/dexamethasone: Reinfection in the form of COVID-19 pneumonia : case report
Publicado: (2021)

Bortezomib/dexamethasone/oxytetracycline: Chalazia, blepharitis and lack of efficacy: case report
Publicado: (2021)

Treatment of scleromyxedema with lenalidomide, bortezomib and dexamethasone: A case report and review of the literature
por: Win, Hninyee, et al.
Publicado: (2020)

Case Report on Renal Failure Reversal in Lambda Chain Multiple Myeloma with Bortezomib and Dexamethasone
por: Patibandla, Bhanu K., et al.
Publicado: (2014)

Fibronectin glomerulopathy with monoclonal gammopathy responding to bortezomib plus dexamethasone: a case report
por: Li, Xiaoli, et al.
Publicado: (2022)

Daratumumab–bortezomib–dexamethasone use in relapsed POEMS syndrome
por: Khwaja, Jahanzaib, et al.
Publicado: (2022)

Complete remission of primary plasma cell leukemia with bortezomib, doxorubicin, and dexamethasone: a case report
por: Chan, Steven M, et al.
Publicado: (2009)

Bortezomib-induced hyponatremia: tolvaptan therapy permits continuation of lenalidomide, bortezomib and dexamethasone therapy in relapsed myeloma
por: O’Connor-Byrne, N., et al.
Publicado: (2019)

A rare case of MGRS with immunotactoid glomerulopathy responding to bortezomib, dexamethasone, and rituximab
por: Kuang, Chaoyuan, et al.
Publicado: (2020)

The Addition of Low-dose Thalidomide to Bortezomib and Dexamethasone for Refractory Multiple Myeloma
por: Hashimoto, Shigeo, et al.
Publicado: (2016)

Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report
por: Noto, Rio, et al.
Publicado: (2017)

First Case of Nodular Localized Primary Cutaneous Amyloidosis Treated With Bortezomib and Dexamethasone
por: Khan, Noman Ahmed Jang, et al.
Publicado: (2021)

Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma
por: Cerchione, Claudio, et al.
Publicado: (2016)

Overcoming Proteasome Inhibitor-Refractory Multiple Myeloma With Elotuzumab, Bortezomib, Nelfinavir, and Dexamethasone
por: Erath, Alexandra, et al.
Publicado: (2020)

Epidural Extramedullary Plasmacytoma Successfully Treated with Surgical Excision and Bortezomib, Cyclophosphamide and Dexamethasone
por: MARTIO, ARTUR EDUARDO, et al.
Publicado: (2023)

Dexamethasone: COVID-19-pneumonia: case report
Publicado: (2022)

A Case of Multiple Myeloma with Metachronous Chronic Myeloid Leukemia Treated Successfully with Bortezomib, Dexamethasone, and Dasatinib
por: Alsidawi, Samer, et al.
Publicado: (2014)

Dexamethasone/gemcitabine/interferon-alpha: COVID-19 infection: 2 case reports
Publicado: (2021)

Selinexor, bortezomib, and dexamethasone versus bortezomib and dexamethasone in previously treated multiple myeloma: Outcomes by cytogenetic risk
por: Richard, Shambavi, et al.
Publicado: (2021)

Dexamethasone: Rebound of COVID-19-pneumonia: case report
Publicado: (2021)

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of CASTOR
por: Spencer, Andrew, et al.
Publicado: (2018)

Treatment of Coexisting Chronic Neutrophilic Leukemia and Light Chain Multiple Myeloma with Hydroxyurea, Bortezomib, and Dexamethasone
por: Taiwo, Evelyn, et al.
Publicado: (2014)

Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach
por: Sabry, Waleed, et al.
Publicado: (2022)

Dexamethasone in severe COVID-19 infection: A case series
por: Hassan, Mohamed Eliwa, et al.
Publicado: (2020)

Dexamethasone/temozolomide: COVID-19 and COVID-19 pneumonia: 5 case reports
Publicado: (2021)

Dexamethasone/hydroxychloroquine: Reactivation of COVID-19 infection and off label use: 4 case reports
Publicado: (2021)

Dexamethasone: Reactivation of amoebic infection: case report
Publicado: (2021)

Dexamethasone: Trichosporon Asahii infection: case report
Publicado: (2022)

Dexamethasone: Klebsiella pneumoniae infection: case report
Publicado: (2022)

Bortezomib/ibrutinib/rituximab: Various toxicities: case report
Publicado: (2021)

Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
Publicado: (2020)

Selinexor, Bortezomib and Dexamethasone: An Effective Salvage Regimen for Heavily Pretreated Myeloma Patients
por: Delforge, Michel, et al.
Publicado: (2022)

Autologous Stem Cell Collection after Daratumumab, Bortezomib, Thalidomide, and Dexamethasone versus Bortezomib, Cyclophosphamide, and Dexamethasone in Newly Diagnosed Multiple Myeloma
por: Sauer, Sandra, et al.
Publicado: (2023)

Management of pancreatitis related to Bortezomib treatment: report of two cases
por: Brulc, Erika, et al.
Publicado: (2018)

Bortezomib/lenalidomide: Interstitial pneumonitis and peripheral neuropathy: case report
Publicado: (2020)

Clinical Resolution of Red Cell Aplasia Associated del 17p Multiple Myeloma, When Treated With Bortezomib and Dexamethasone
por: Ladha, Abdullah, et al.
Publicado: (2018)

Persistent hiccups after treatment of COVID-19 with dexamethasone: A case report
por: Karampoor, Sajad, et al.
Publicado: (2021)

Pulmonary embolism after dexamethasone treatment for COVID-19: a case report
por: Takahashi, Hidenori, et al.
Publicado: (2022)

Efficacy of bortezomib, cyclophosphamide and dexamethasone in cardiac AL amyloidosis
por: Brennan, Xavier, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o00mt2lut1fm2lo69ns79qrdfg